Principal Financial Group Inc. Trims Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Principal Financial Group Inc. lessened its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 4.0% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,955,615 shares of the company's stock after selling 122,333 shares during the period. Principal Financial Group Inc. owned 2.44% of Privia Health Group worth $66,354,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in PRVA. EverSource Wealth Advisors LLC boosted its holdings in shares of Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock valued at $47,000 after purchasing an additional 2,350 shares during the last quarter. Bessemer Group Inc. boosted its holdings in shares of Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock valued at $51,000 after purchasing an additional 2,178 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock valued at $64,000 after purchasing an additional 1,521 shares during the last quarter. Financial Management Professionals Inc. boosted its holdings in shares of Privia Health Group by 28.7% during the 1st quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company's stock valued at $76,000 after purchasing an additional 754 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its holdings in shares of Privia Health Group by 11.8% in the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock valued at $95,000 after acquiring an additional 511 shares during the last quarter. Institutional investors own 94.48% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently commented on PRVA shares. Truist Financial increased their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a report on Thursday, April 10th. JPMorgan Chase & Co. increased their price target on shares of Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a report on Wednesday, May 28th. Needham & Company LLC reissued a "buy" rating and issued a $30.00 price objective on shares of Privia Health Group in a research report on Thursday, April 10th. JMP Securities reissued a "market outperform" rating and issued a $29.00 price objective on shares of Privia Health Group in a research report on Monday, April 28th. Finally, Robert W. Baird increased their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $27.77.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA traded up $0.18 during trading on Tuesday, reaching $21.53. 220,597 shares of the company were exchanged, compared to its average volume of 762,487. The firm has a market capitalization of $2.62 billion, a PE ratio of 179.43, a P/E/G ratio of 3.54 and a beta of 0.82. The business's fifty day simple moving average is $23.05 and its 200-day simple moving average is $22.93. Privia Health Group, Inc. has a 12-month low of $16.47 and a 12-month high of $26.09.

Insider Transactions at Privia Health Group

In other news, CFO David Mountcastle sold 3,445 shares of the firm's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $80,371.85. Following the transaction, the chief financial officer directly owned 176,231 shares of the company's stock, valued at approximately $4,111,469.23. This trade represents a 1.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Parth Mehrotra sold 15,100 shares of Privia Health Group stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $352,283.00. Following the transaction, the chief executive officer directly owned 454,281 shares in the company, valued at approximately $10,598,375.73. The trade was a 3.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 45,949 shares of company stock valued at $1,100,368. 10.70% of the stock is currently owned by company insiders.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.